Reply to "Response assessment for HCC patients treated with repeated TACE: The optimal time-point is still an open issue"

Affiliations

¹ Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Republic of Korea.
² Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Republic of Korea. Electronic address: ksukorea@yuhs.ac.

Comment

Beom Kyung Kim et al. J Hepatol. 2015 Dec.

. 2015 Dec;63(6):1532.

doi: 10.1016/j.jhep.2015.09.003. Epub 2015 Sep 12.

¹ Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Republic of Korea.
² Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Republic of Korea. Electronic address: ksukorea@yuhs.ac.

No abstract available

Comment on

Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma.
Kim BK, Kim SU, Kim KA, Chung YE, Kim MJ, Park MS, Park JY, Kim DY, Ahn SH, Kim MD, Park SI, Won JY, Lee DY, Han KH. Kim BK, et al. J Hepatol. 2015 Jun;62(6):1304-10. doi: 10.1016/j.jhep.2015.01.022. Epub 2015 Jan 29. J Hepatol. 2015. PMID: 25637785
Response assessment for HCC patients treated with repeated TACE: The optimal time-point is still an open issue.
Wang W, Zhao Y, Bai W, Han G. Wang W, et al. J Hepatol. 2015 Dec;63(6):1530-1. doi: 10.1016/j.jhep.2015.07.031. Epub 2015 Aug 6. J Hepatol. 2015. PMID: 26256436 No abstract available.